.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
McKinsey
Daiichi Sankyo
AstraZeneca
Covington
Julphar
Federal Trade Commission
Mallinckrodt
Chinese Patent Office
Colorcon

Generated: June 27, 2017

DrugPatentWatch Database Preview

MD-50 Drug Profile

« Back to Dashboard

What is the patent landscape for Md-50, and when can generic versions of Md-50 launch?

Md-50 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in MD-50 is diatrizoate sodium. There are nine drug master file entries for this compound. Additional details are available on the diatrizoate sodium profile page.

Summary for Tradename: MD-50

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list82
Patent Applications: see list2,808
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MD-50 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt
MD-50
diatrizoate sodium
INJECTABLE;INJECTION087075-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
US Department of Justice
Mallinckrodt
Cantor Fitzgerald
Cerilliant
Colorcon
Chubb
Fuji
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot